Variant report

Variant	nsv875746
Chromosome Location	chr2:208971007-208989708
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:111)
CpG islands
(count:1160)
Chromatin interactive
region (count:4)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:111 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr2:208989435-208989474	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr2:208971322-208971335	H1-hESC	embryonic stem cell:	n/a	n/a
3	BRCA1	chr2:208977581-208978020	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr2:208976666-208976729	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr2:208977669-208978022	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr2:208984500-208984694	HepG2	liver:	n/a	chr2:208984649-208984660
7	CEBPB	chr2:208977579-208978082	MCF-7	breast:	n/a	n/a
8	CTCF	chr2:208977340-208977490	HEK293	kidney:	n/a	n/a
9	CTCF	chr2:208980609-208980614	GM20000	blood:	n/a	n/a
10	EBF1	chr2:208979727-208979939	GM12878	blood:	n/a	n/a
11	EBF1	chr2:208979719-208979944	GM12878	blood:	n/a	n/a
12	EP300	chr2:208977697-208978032	Hela-S3	cervix:	n/a	n/a
13	EP300	chr2:208989076-208989430	H1-hESC	embryonic stem cell:	n/a	chr2:208989351-208989365 chr2:208989353-208989367
14	FOXA1	chr2:208981635-208981884	HepG2	liver:	n/a	n/a
15	FOXA1	chr2:208977687-208978007	T-47D	breast:	n/a	chr2:208977821-208977836
16	FOXA1	chr2:208977665-208977947	T-47D	breast:	n/a	chr2:208977821-208977836
17	FOXA2	chr2:208981605-208981868	HepG2	liver:	n/a	n/a
18	GATA2	chr2:208982079-208982439	K562	blood:	n/a	n/a
19	GATA2	chr2:208977776-208978015	SH-SY5Y	brain:	n/a	chr2:208977894-208977901
20	GATA3	chr2:208977680-208977997	T-47D	breast:	n/a	chr2:208977894-208977901
21	GATA3	chr2:208977672-208978004	T-47D	breast:	n/a	chr2:208977894-208977901
22	GATA3	chr2:208977479-208978321	MCF-7	breast:	n/a	chr2:208977894-208977901
23	GATA3	chr2:208977683-208978104	MCF-7	breast:	n/a	chr2:208977894-208977901
24	GATA3	chr2:208977691-208977969	MCF-7	breast:	n/a	chr2:208977894-208977901
25	GATA3	chr2:208977518-208978320	MCF-7	breast:	n/a	chr2:208977894-208977901
26	GTF2F1	chr2:208977428-208977977	H1-hESC	embryonic stem cell:	n/a	n/a
27	HDAC2	chr2:208977673-208978123	MCF-7	breast:	n/a	n/a
28	HDAC2	chr2:208977563-208978158	MCF-7	breast:	n/a	n/a
29	IRF1	chr2:208977828-208977969	K562	blood:	n/a	n/a
30	JUN	chr2:208989453-208989476	H1-hESC	embryonic stem cell:	n/a	n/a
31	JUND	chr2:208977914-208978040	H1-hESC	embryonic stem cell:	n/a	n/a
32	JUND	chr2:208986075-208986320	HepG2	liver:	n/a	n/a
33	KAP1	chr2:208977575-208978211	HEK293	kidney:	n/a	n/a
34	KAP1	chr2:208977537-208978187	U2OS	brain:	n/a	n/a
35	MAX	chr2:208977703-208978076	Hela-S3	cervix:	n/a	n/a
36	MAX	chr2:208989020-208989338	H1-hESC	embryonic stem cell:	n/a	n/a
37	MAX	chr2:208977636-208978123	H1-hESC	embryonic stem cell:	n/a	n/a
38	MAX	chr2:208976514-208976575	H1-hESC	embryonic stem cell:	n/a	n/a
39	MAX	chr2:208977552-208978187	MCF-7	breast:	n/a	n/a
40	MAX	chr2:208977635-208978076	Hela-S3	cervix:	n/a	n/a
41	MAX	chr2:208977641-208978157	MCF-7	breast:	n/a	n/a
42	MAX	chr2:208976749-208977004	H1-hESC	embryonic stem cell:	n/a	n/a
43	MAZ	chr2:208977734-208978110	Hela-S3	cervix:	n/a	n/a
44	MYC	chr2:208977803-208977816	Hela-S3	cervix:	n/a	n/a
45	MYC	chr2:208988856-208989006	MCF-7	breast:	n/a	n/a
46	NR2F2	chr2:208977559-208978214	MCF-7	breast:	n/a	n/a
47	NR2F2	chr2:208982125-208982427	K562	blood:	n/a	n/a
48	POLR2A	chr2:208989191-208989274	H1-hESC	embryonic stem cell:	n/a	n/a
49	POLR2A	chr2:208976595-208976713	H1-hESC	embryonic stem cell:	n/a	n/a
50	POLR2A	chr2:208972626-208972653	H1-hESC	embryonic stem cell:	n/a	n/a

(count:1160 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:208989469-208989519	HNPCEpiC	eye:	n/a
2	chr2:208989469-208989519	HNPCEpiC	eye:	n/a
3	chr2:208988453-208988503	PANC-1	pancreas:	n/a
4	chr2:208977452-208977502	HUVEC	blood vessel:	n/a
5	chr2:208989579-208989629	HRE	kidney:	n/a
6	chr2:208988453-208988503	LNCaP	prostate:	n/a
7	chr2:208989324-208989374	Jurkat	blood:	n/a
8	chr2:208986497-208986547	NB4	blood:	n/a
9	chr2:208989425-208989475	HepG2	liver:	n/a
10	chr2:208989469-208989519	HCPEpiC	choroid plexus:	n/a
11	chr2:208989209-208989259	Hepatocyte	liver:	n/a
12	chr2:208977452-208977502	ovcar-3	ovarian:	n/a
13	chr2:208977452-208977502	BJ	skin:	n/a
14	chr2:208989209-208989259	HCF	heart:	n/a
15	chr2:208988967-208989017	IMR90	lung:	fetal
16	chr2:208989209-208989259	HEK293	kidney:	embryo
17	chr2:208986497-208986547	HRPEpiC	eye:	n/a
18	chr2:208988967-208989017	NHDF-neo	bronchial:	n/a
19	chr2:208988932-208988982	NH-A	brain:	n/a
20	chr2:208975126-208975176	T-47D	breast:	n/a
21	chr2:208988967-208989017	HRCEpiC	kidney:	n/a
22	chr2:208976637-208976687	NH-A	brain:	n/a
23	chr2:208977395-208977445	CMK	blood:	n/a
24	chr2:208976637-208976687	HepG2	liver:	n/a
25	chr2:208989248-208989298	HCF	heart:	n/a
26	chr2:208988453-208988503	AoSMC	blood vessel:	n/a
27	chr2:208988967-208989017	CMK	blood:	n/a
28	chr2:208976637-208976687	AG09309	skin:	n/a
29	chr2:208975126-208975176	K562	blood:	n/a
30	chr2:208973097-208973147	HRCEpiC	kidney:	n/a
31	chr2:208988932-208988982	HL-60	blood:	n/a
32	chr2:208973097-208973147	GM06990	blood:	n/a
33	chr2:208977121-208977171	NT2-D1	testis:	n/a
34	chr2:208989382-208989432	HUVEC	blood vessel:	n/a
35	chr2:208989248-208989298	A549	lung:	n/a
36	chr2:208977395-208977445	T-47D	breast:	n/a
37	chr2:208988453-208988503	HUVEC	blood vessel:	n/a
38	chr2:208977395-208977445	HCT-116	colon:	n/a
39	chr2:208986497-208986547	NHDF-neo	bronchial:	n/a
40	chr2:208989248-208989298	GM12891	blood:	n/a
41	chr2:208976637-208976687	Caco-2	colon:	n/a
42	chr2:208988863-208988913	GM12891	blood:	n/a
43	chr2:208977395-208977445	AG09309	skin:	n/a
44	chr2:208989324-208989374	AG10803	skin:	n/a
45	chr2:208989324-208989374	HNPCEpiC	eye:	n/a
46	chr2:208975126-208975176	Hepatocyte	liver:	n/a
47	chr2:208977452-208977502	Hela-S3	cervix:	n/a
48	chr2:208976933-208976983	HAEpiC	amniotic membrane:	n/a
49	chr2:208989425-208989475	LNCaP	prostate:	n/a
50	chr2:208989248-208989298	ovcar-3	ovarian:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:208973001..208975909-chr2:208979754..208981880,3	MCF-7	breast:
2	chr2:208969150..208970998-chr2:208972838..208975738,2	K562	blood:
3	chr2:208973001..208975909-chr2:208979754..208981880,3	MCF-7	breast:
4	chr2:208989109..208991585-chr2:208994453..208996077,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PIKFYVE-4	chr2:208983830-208983949	NONHSAT076630
2	lnc-PIKFYVE-4	chr2:208983853-208983949	NONHSAT076632
3	lnc-PIKFYVE-4	chr2:208983830-208983949	NONHSAT076631

No data

Variant related genes	Relation type
CRYGEP	TF binding region
CRYGD	TF binding region
CRYGEP	CpG island
CRYGD	CpG island
ENSG00000163254	chromatin interactions

Extended variants
information (count: 896 )
Associated
traits (count: 53 )

Variant overlapped rSNPs/rCNVs (count:896 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10181061	chr2:208971007-208971008	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs79037877	chr2:208971020-208971021	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs574146406	chr2:208971050-208971051	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs542066538	chr2:208971108-208971109	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs191096310	chr2:208971114-208971115	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs527479504	chr2:208971135-208971136	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs370598325	chr2:208971144-208971145	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs375298554	chr2:208971145-208971146	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs6732301	chr2:208971148-208971149	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs538740903	chr2:208971152-208971153	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs530393326	chr2:208971182-208971183	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs532770018	chr2:208971189-208971190	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs146522786	chr2:208971239-208971240	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs569430275	chr2:208971279-208971280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs528929856	chr2:208971300-208971301	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs79541328	chr2:208971305-208971306	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs149101182	chr2:208971339-208971340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs534900893	chr2:208971346-208971347	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs558427942	chr2:208971382-208971383	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs571926609	chr2:208971395-208971396	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs183502454	chr2:208971423-208971424	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs567381194	chr2:208971433-208971434	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs557363377	chr2:208971459-208971460	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs574060928	chr2:208971529-208971530	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs543140982	chr2:208971562-208971563	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs187463801	chr2:208971570-208971571	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs572251178	chr2:208971589-208971590	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs76541254	chr2:208971635-208971636	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
29	rs10932239	chr2:208971645-208971646	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs533024806	chr2:208971652-208971653	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs543038021	chr2:208971664-208971665	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs542549127	chr2:208971688-208971689	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs376132995	chr2:208971690-208971691	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs143657745	chr2:208971691-208971692	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs536419069	chr2:208971747-208971748	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs190793234	chr2:208971753-208971754	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs565589595	chr2:208971760-208971761	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs115435507	chr2:208971874-208971875	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs10932240	chr2:208971875-208971876	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs6435410	chr2:208971883-208971884	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs151036093	chr2:208971921-208971922	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs557671246	chr2:208971932-208971933	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs567703941	chr2:208971950-208971951	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs61370782	chr2:208971964-208971965	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs553435561	chr2:208971966-208971967	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs367875622	chr2:208971993-208971994	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs141011571	chr2:208972011-208972012	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs182979110	chr2:208972014-208972015	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs115241458	chr2:208972073-208972074	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs543350228	chr2:208972078-208972079	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:53)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Cervical cancer	21062161	CNVD
Intracranial aneurysm	16715129	CNVD
Hepatocellular carcinoma	16750200	CNVD
Prostate cancer	16573809	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Glioblastoma multiforme	22286061	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Non-small cell lung cancer	21829676	CNVD
Autism	20808228	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:298 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:208965000-208976600	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr2:208967400-208972000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr2:208967400-208976800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr2:208968600-208972000	Weak transcription	H1 Cell Line	embryonic stem cell
5	chr2:208969400-208971800	Weak transcription	HUES64 Cell Line	embryonic stem cell
6	chr2:208969400-208972000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
7	chr2:208969400-208976600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
8	chr2:208970800-208971400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr2:208971000-208971400	Enhancers	Placenta Amnion	Placenta Amnion
10	chr2:208971200-208972200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr2:208971400-208971800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr2:208971800-208972000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
13	chr2:208971800-208972600	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr2:208972000-208973000	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr2:208972000-208973000	Enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr2:208972000-208973200	Enhancers	H1 Cell Line	embryonic stem cell
17	chr2:208972000-208973200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
18	chr2:208972200-208972600	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr2:208972200-208972800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr2:208972600-208976200	Weak transcription	HUES64 Cell Line	embryonic stem cell
21	chr2:208972600-208976600	Weak transcription	HUES48 Cell Line	embryonic stem cell
22	chr2:208972800-208973200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr2:208973000-208973200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
24	chr2:208973000-208975600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
25	chr2:208973000-208976200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
26	chr2:208973200-208975600	Weak transcription	H1 Cell Line	embryonic stem cell
27	chr2:208973200-208976600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
28	chr2:208973200-208976800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr2:208973200-208989000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr2:208975600-208976200	Enhancers	iPS-18 Cell Line	embryonic stem cell
31	chr2:208975600-208976400	Enhancers	H1 Cell Line	embryonic stem cell
32	chr2:208976000-208976200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
33	chr2:208976200-208976400	Active TSS	HUES64 Cell Line	embryonic stem cell
34	chr2:208976200-208976400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
35	chr2:208976200-208976400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
36	chr2:208976200-208976600	Enhancers	ES-I3 Cell Line	embryonic stem cell
37	chr2:208976200-208977600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr2:208976400-208976600	Active TSS	H1 Cell Line	embryonic stem cell
39	chr2:208976400-208976600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
40	chr2:208976400-208976600	Active TSS	iPS-18 Cell Line	embryonic stem cell
41	chr2:208976400-208976600	Active TSS	iPS-20b Cell Line	embryonic stem cell
42	chr2:208976600-208976800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
43	chr2:208976600-208976800	Flanking Active TSS	H1 Cell Line	embryonic stem cell
44	chr2:208976600-208976800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr2:208976600-208976800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
46	chr2:208976600-208976800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
47	chr2:208976600-208976800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
48	chr2:208976600-208976800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
49	chr2:208976600-208976800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
50	chr2:208976600-208976800	Enhancers	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links